Skip to Content
Søk Menu

MEDtalks

Senaste MEDtalk

Ingrid Cecilia Glimelius

Novel Clinical Data in Mantle Cell Lymphoma Highlighted in ASH 2025 Oral Session

/ Ingrid Cecilia Glimelius
ASH25 Play the Video
Ingrid Cecilia Glimelius

Nordic Study Uncovers a New Minimally Invasive Biomarker for Low-Risk Mantle Cell Lymphoma

/ Ingrid Cecilia Glimelius
ASH25 Play the Video

Henrik Hjorth-Hansen

Improving CML Outcomes: Nordic CML Study Group Shares New ASH 2025 Insights

/ Henrik Hjorth-Hansen
ASH25Lymfom Play the Video
Wojciech Jurczak

Pirtobrutinib Showed Positive Efficacy and Safety vs Ibrutinib in BTKi-naïve CLL/SLL Patients Both for Treatment-naïve Patients and Patients with R/R Disease

/ Wojciech Jurczak
ASH25CLL Play the Video
Marcus Skribek

New Prognostic Tool for Immune Checkpoint Inhibitor-treated NSCLC

/ Marcus Skribek
WCLC25 Play the Video
Waleed Ghanima

Norwegian Study Can Change the Clinical Practice for Patients with Immune Thrombocytopenia

/ Waleed Ghanima
ASH25 Play the Video
Jelena Jelicic

Danish Study Finds That Variability in Eligibility Criteria Hampers Comparability of Frontline DLBCL Trials

/ Jelena Jelicic
ASH25Lymfom Play the Video
Astrid Hundeboell Torpe

ASH 2025: Prophylactic Tocilizumab Reduces CRS

/ Astrid Hundebøll Torpe
ASH25Multiple myeloma Play the Video

One-Size-Fits-All No Longer Applies in Bladder Cancer Care

/ Alison Birtle
Blåscancer Play the Video
Sandra Jensen

Metastatic Deposit Size as a Predictor of Axillary Disease After Neoadjuvant Chemotherapy

/ Sandra Jensen
BröstcancerNBCN Play the Video
Marco Donia

Uveal melanoma: ESMO 2025 updates in 2 minutes

/ Marco Donia
ESMO25Melanom Play the Video
Marco Donia

Metastatic melanoma: ESMO 2025 updates in 2 minutes

/ Marco Donia
ESMO25Melanom Play the Video
Marco Donia

Neoadjuvant melanoma: ESMO 2025 updates in 2 minutes

/ Marco Donia
ESMO25Melanom Play the Video
Teresa Macarulla

ESMO 2025: HER2-Targeted Therapy Advances in BTC

/ Teresa Macarulla
ESMO25NBCN Play the Video
Load more
Matilde Grupe Frost

Gender-Based Outcomes in Advanced NSCLC

/ Matilde Grupe Frost
LungcancerNSCLC Play the Video
Jonatan Ruiz-Molsgaard

UEGW 2025: AI Models Enhance Gastrointestinal Disease Diagnosis and Treatment

/ Jonatan Ruiz-Molsgaard
UEGW25 Play the Video
Peeter Karihtala

The Clinical Value of Immuno-Oncological Treatments in Early Breast Cancer

/ Peeter Karihtala
Bröstcancer Play the Video
Ricard Cervera

New Classification and Treatment Strategies in Antiphospholipid Syndrome

/ Ricard Cervera
Autoimmuna sjukdomar Play the Video
Katharina Leuchte

ESMO 2025: High-Intensity Interval Training Promotes Immune Responses in mNSCLC Patients

/ Katharina Leuchte
ESMO25Lungcancer Play the Video
John Crown

ESMO 2025: Ribociclib + NSAI Reduced the Risk of Invasive and Distant Recurrence of HR+/HER2−Early Breast Cancer

/ John Crown
BröstcancerESMO25NBCN Play the Video
Charles Geyer

ESMO 2025: Paradigm Shift in Breast Cancer Treatment

/ Charles E Geyer Jr.
BröstcancerESMO25NBCN Play the Video
Jakob Lauritsen

ESMO 2025: Interesting New Data on the Treatment of Bladder Cancer

/ Jakob Lauritsen
BlåscancerESMO25 Play the Video
Hildur Helgadottir

ESMO 2025: Superior Outcomes With Reduced NIVO+IPI Dose in Advanced Melanoma

/ Hildur Helgadottir
ESMO25Melanom Play the Video
Gloria Dalla Costa

ECTRIMS 2025: Ultra-Processed Food Intake is Linked to Increased MS Disease Activity

/ Gloria Dalla Costa
ECTRIMS25 Play the Video
Katarina Puco

ESMO 2025: Precision Medicine Trial Shows Promise in Rare Cancers

/ Katarina Puco
ESMO25 Play the Video

ESMO 2025: Advancements to Improve Patient Outcomes and Quality of Life in Immunotherapy

/ Christina Ruhlmann
ESMO25 Play the Video
Mer
Back to top